NEW YORK(GenomeWeb) — Danaher today initiated guidance for adjusted diluted EPS for 2015 in the range of $4.35 to $4.45. 

The guidance assumes core revenue growth of 3 percent to 4 percent and excludes anticipated non-cash amortization for 2015 of $440 million, or $.46 per share, compared to about $380 million, or $40 per share, in 2014.  

The company also reaffirmed GAAP diluted EPS for the fourth quarter of 2014 to be in the range of $1 to $1.04. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.